簡要描述:
NK-92(人惡性非霍奇金淋巴瘤患者的自然殺傷細(xì)胞)本公司長期經(jīng)營、抗體、細(xì)胞因子、生化試劑、實驗耗材、儀器等生物化學(xué)試劑產(chǎn)品。主營各類進(jìn)口國產(chǎn)優(yōu)質(zhì)細(xì)胞,誠信經(jīng)營,價格實惠,服務(wù)周到,質(zhì)量有保證。詳細(xì)情況請咨詢銷售人員。
更新時間:2021-06-09;廠商性質(zhì):經(jīng)銷商;覽量:653
NK-92(人惡性非霍奇金淋巴瘤患者的自然殺傷細(xì)胞)
ATCC
NK-92 is an interleukin-2 (IL-2) dependent Natural Killer Cell line derived from peripheral blood mononuclear cells from a 50 year old Caucasian male with rapidly progressive non-Hodgkin's lymphoma. [38894]
The cell line is dependent on the presence of recombinant Il-2 and a dose as low as 10 U/ml is sufficient to maintain proliferation; cells will die within 72 hours in the absence of IL-2. [38894]
細(xì)胞(Cell):能進(jìn)行獨立繁殖的有膜包圍的生物體的基本結(jié)構(gòu)和功能單位。一般由質(zhì)膜、細(xì)胞質(zhì)和(或擬核)構(gòu)成,是生命活動的基本單位。
本公司 誠信經(jīng)營生物化學(xué)試劑產(chǎn)品,價格實惠,服務(wù)周到,質(zhì)量有保證
NK-92(人惡性非霍奇金淋巴瘤患者的自然殺傷細(xì)胞)其它相關(guān)產(chǎn)品:
NK-92MI(人惡性非霍奇金淋巴瘤患者的自然殺傷細(xì)胞) ATCC 株
HMy2.CIR(人B 淋巴母細(xì)胞) ATCC 株
OK(負(fù)鼠(opossum)腎細(xì)胞) ATCC 株
FO(骨髓瘤細(xì)胞) ATCC 株
RAW 264.7(單核巨噬細(xì)胞白血?。?nbsp; ATCC 株
P19(畸胎癌細(xì)胞) ATCC 株
C6(膠質(zhì)瘤細(xì)胞) ATCC 株
RBL-2H3(白血病細(xì)胞) ATCC 株
SiHa(子宮頸癌細(xì)胞) ATCC 株
MG-63(骨肉瘤細(xì)胞) ATCC 株
HEC-1-B(子宮內(nèi)膜腺癌細(xì)胞) ATCC 株
SW1353(骨肉瘤細(xì)胞) ATCC 株
ES-2(卵巢透明細(xì)胞癌細(xì)胞) ATCC 株
Saos-2(成骨肉瘤細(xì)胞) ATCC 株
MDA-MB-468(乳腺癌細(xì)胞) ATCC 株
SK-MES-1(肺鱗癌細(xì)胞) ATCC 株
MDA-MB-435S(乳腺癌細(xì)胞) ATCC 株
NCI-H661(大細(xì)胞肺癌細(xì)胞) ATCC 株
ZR-75-1(乳腺癌細(xì)胞) ATCC 株
NCI-H292(肺癌細(xì)胞(淋巴結(jié)轉(zhuǎn)移)) ATCC 株
Hs 578T(乳腺癌細(xì)胞) ATCC 株
U-937(組織細(xì)胞淋巴瘤細(xì)胞) ATCC 株
CFPAC-1(胰腺癌細(xì)胞) ATCC 株
A3(淋巴細(xì)胞白血病細(xì)胞) ATCC 株
PANC-1(胰腺癌細(xì)胞) ATCC 株
供應(yīng)商